INSIGHTS ON DRUG DEVELOPMENT

• Beyond SOPs: Assessing Quality Of CDMOs

  When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.

• A Study To Assess Organoid Size And Cell Count From 3D Image Analysis

  Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

• Simplify Your Cell Culture Processes

  Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

• Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody

  Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

• ADC Tech Talks Contract Manufacturing

  12/9/2024

  Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.

• The Role Of A Consulting Firm In The IND Process

  6/10/2025

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

• Overcoming Excipient Risks And Challenges For Parenteral Formulations

  8/27/2025

  Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

• A Better Immune Response To Vaccination: Using Lymphoid Follicle Organ-Chips

  4/9/2024

  Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.

• Assessing Production And Stability Of Antibody Drug Conjugate Platforms

  9/24/2025

  ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.